APO Research
Talk to an analyst

APO RESEARCH · REPORT

Healthcare Apps for Patients

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Healthcare Apps for Patients Market Outlook and Growth Opportunities 2026

6 January 2026202 pages

Choose your research edition.

Industry ResearchHealthcare Apps for Patients Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Healthcare Apps for Patients Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Healthcare Apps for Patients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Healthcare Apps for Patients Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Healthcare Apps for Patients Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Healthcare Apps for Patients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Healthcare Apps for Patients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Healthcare Apps for Patients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Healthcare Apps for Patients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Healthcare Apps for Patients market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Healthcare Apps for Patients market include Medisafe, Medical ID, Dminder, MyFitnessPal, Diabetes:M, Heal, Eyecare Live, AliveCor and mySymptoms, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Healthcare Apps for Patients market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Healthcare Apps for Patients and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Healthcare Apps for Patients revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Healthcare Apps for Patients market.

Healthcare Apps for Patients Segment by Company

Medisafe

Medical ID

Dminder

MyFitnessPal

Diabetes:M

Heal

Eyecare Live

AliveCor

mySymptoms

Teladoc

Epocrates

Eyecarelive

MyChart

Doximity

Amwell

UpToDate

Healthcare Apps for Patients Segment by Type

iOS

Android

Healthcare Apps for Patients Segment by Application

Patients

Relatives of Patient

Healthcare Apps for Patients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Healthcare Apps for Patients status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Healthcare Apps for Patients key companies, revenue, market share, and recent developments.

3. To split the Healthcare Apps for Patients breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Healthcare Apps for Patients market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Healthcare Apps for Patients significant trends, drivers, influence factors in global and regions.

6. To analyze Healthcare Apps for Patients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Healthcare Apps for Patients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Healthcare Apps for Patients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Healthcare Apps for Patients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Healthcare Apps for Patients industry.

Chapter 3: Detailed analysis of Healthcare Apps for Patients company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Healthcare Apps for Patients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Healthcare Apps for Patients in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Healthcare Apps for Patients Industry Trends Table 2. Healthcare Apps for Patients Industry Drivers Table 3. Healthcare Apps for Patients Industry Opportunities and Challenges Table 4. Healthcare Apps for Patients Industry Restraints Table 5. Global Healthcare Apps for Patients Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Healthcare Apps for Patients Revenue Share by Company (2021-2026) Table 7. Global Healthcare Apps for Patients Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Healthcare Apps for Patients Key Company Manufacturing Base & Headquarters Table 9. Global Healthcare Apps for Patients Company, Product Type & Application Table 10. Global Healthcare Apps for Patients Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Healthcare Apps for Patients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of iOS Table 15. Significant Companies of Android Table 16. Global Healthcare Apps for Patients Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Healthcare Apps for Patients Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Healthcare Apps for Patients Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Healthcare Apps for Patients Sales Value Share by Type (2021-2026) Table 20. Global Healthcare Apps for Patients Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Patients Table 22. Significant Companies of Relatives of Patient Table 23. Global Healthcare Apps for Patients Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Healthcare Apps for Patients Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Healthcare Apps for Patients Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Healthcare Apps for Patients Sales Value Share by Application (2021-2026) Table 27. Global Healthcare Apps for Patients Sales Value Share by Application (2027-2032) Table 28. Global Healthcare Apps for Patients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Healthcare Apps for Patients Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Healthcare Apps for Patients Sales Value Share by Region (2021-2026) Table 31. Global Healthcare Apps for Patients Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Healthcare Apps for Patients Sales Value Share by Region (2027-2032) Table 33. Global Healthcare Apps for Patients Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Healthcare Apps for Patients Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Healthcare Apps for Patients Sales Value Market Share by Country (2021-2026) Table 36. Global Healthcare Apps for Patients Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Healthcare Apps for Patients Sales Value Market Share by Country (2027-2032) Table 38. Medisafe Company Information Table 39. Medisafe Business Overview Table 40. Medisafe Healthcare Apps for Patients Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Medisafe Healthcare Apps for Patients Product Portfolio Table 42. Medisafe Recent Development Table 43. Medical ID Company Information Table 44. Medical ID Business Overview Table 45. Medical ID Healthcare Apps for Patients Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Medical ID Healthcare Apps for Patients Product Portfolio Table 47. Medical ID Recent Development Table 48. Dminder Company Information Table 49. Dminder Business Overview Table 50. Dminder Healthcare Apps for Patients Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Dminder Healthcare Apps for Patients Product Portfolio Table 52. Dminder Recent Development Table 53. MyFitnessPal Company Information Table 54. MyFitnessPal Business Overview Table 55. MyFitnessPal Healthcare Apps for Patients Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. MyFitnessPal Healthcare Apps for Patients Product Portfolio Table 57. MyFitnessPal Recent Development Table 58. Diabetes:M Company Information Table 59. Diabetes:M Business Overview Table 60. Diabetes:M Healthcare Apps for Patients Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Diabetes:M Healthcare Apps for Patients Product Portfolio Table 62. Diabetes:M Recent Development Table 63. Heal Company Information Table 64. Heal Business Overview Table 65. Heal Healthcare Apps for Patients Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Heal Healthcare Apps for Patients Product Portfolio Table 67. Heal Recent Development Table 68. Eyecare Live Company Information Table 69. Eyecare Live Business Overview Table 70. Eyecare Live Healthcare Apps for Patients Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Eyecare Live Healthcare Apps for Patients Product Portfolio Table 72. Eyecare Live Recent Development Table 73. AliveCor Company Information Table 74. AliveCor Business Overview Table 75. AliveCor Healthcare Apps for Patients Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. AliveCor Healthcare Apps for Patients Product Portfolio Table 77. AliveCor Recent Development Table 78. mySymptoms Company Information Table 79. mySymptoms Business Overview Table 80. mySymptoms Healthcare Apps for Patients Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. mySymptoms Healthcare Apps for Patients Product Portfolio Table 82. mySymptoms Recent Development Table 83. Teladoc Company Information Table 84. Teladoc Business Overview Table 85. Teladoc Healthcare Apps for Patients Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Teladoc Healthcare Apps for Patients Product Portfolio Table 87. Teladoc Recent Development Table 88. Epocrates Company Information Table 89. Epocrates Business Overview Table 90. Epocrates Healthcare Apps for Patients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Epocrates Healthcare Apps for Patients Product Portfolio Table 92. Epocrates Recent Development Table 93. Eyecarelive Company Information Table 94. Eyecarelive Business Overview Table 95. Eyecarelive Healthcare Apps for Patients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Eyecarelive Healthcare Apps for Patients Product Portfolio Table 97. Eyecarelive Recent Development Table 98. MyChart Company Information Table 99. MyChart Business Overview Table 100. MyChart Healthcare Apps for Patients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. MyChart Healthcare Apps for Patients Product Portfolio Table 102. MyChart Recent Development Table 103. Doximity Company Information Table 104. Doximity Business Overview Table 105. Doximity Healthcare Apps for Patients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Doximity Healthcare Apps for Patients Product Portfolio Table 107. Doximity Recent Development Table 108. Amwell Company Information Table 109. Amwell Business Overview Table 110. Amwell Healthcare Apps for Patients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Amwell Healthcare Apps for Patients Product Portfolio Table 112. Amwell Recent Development Table 113. UpToDate Company Information Table 114. UpToDate Business Overview Table 115. UpToDate Healthcare Apps for Patients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. UpToDate Healthcare Apps for Patients Product Portfolio Table 117. UpToDate Recent Development Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Healthcare Apps for Patients Product Image Figure 2. Global Healthcare Apps for Patients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Healthcare Apps for Patients Market Size (2021-2032) & (US$ Million) Figure 4. Global Healthcare Apps for Patients Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. iOS Image Figure 8. Android Image Figure 9. Global Healthcare Apps for Patients Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Healthcare Apps for Patients Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Healthcare Apps for Patients Sales Value Share by Type (2021-2032) Figure 12. Patients Image Figure 13. Relatives of Patient Image Figure 14. Global Healthcare Apps for Patients Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Healthcare Apps for Patients Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Healthcare Apps for Patients Sales Value Share by Application (2021-2032) Figure 17. Global Healthcare Apps for Patients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Healthcare Apps for Patients Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Healthcare Apps for Patients Sales Value (2021-2032) & (US$ Million) Figure 20. North America Healthcare Apps for Patients Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Healthcare Apps for Patients Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Healthcare Apps for Patients Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Healthcare Apps for Patients Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Healthcare Apps for Patients Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Healthcare Apps for Patients Sales Value (2021-2032) & (US$ Million) Figure 26. South America Healthcare Apps for Patients Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Healthcare Apps for Patients Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Healthcare Apps for Patients Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Healthcare Apps for Patients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • iOS
  • Android
Applications
  • Patients
  • Relatives of Patient
Companies covered
  • Medisafe
  • Medical ID
  • Dminder
  • MyFitnessPal
  • Diabetes:M
  • Heal
  • Eyecare Live
  • AliveCor
  • mySymptoms
  • Teladoc
  • Epocrates
  • Eyecarelive
  • MyChart
  • Doximity
  • Amwell
  • UpToDate

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Healthcare Apps for Patients Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Healthcare Apps for Patients Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Healthcare Apps for Patients Market Dynamics
  1. 2.1 Healthcare Apps for Patients Industry Trends
  2. 2.2 Healthcare Apps for Patients Industry Drivers
  3. 2.3 Healthcare Apps for Patients Industry Opportunities and Challenges
  4. 2.4 Healthcare Apps for Patients Industry Restraints
3 Healthcare Apps for Patients Market by Company
  1. 3.1 Global Healthcare Apps for Patients Company Revenue Ranking in 2025
  2. 3.2 Global Healthcare Apps for Patients Revenue by Company (2021-2026)
  3. 3.3 Global Healthcare Apps for Patients Company Ranking (2024-2026)
  4. 3.4 Global Healthcare Apps for Patients Company Manufacturing Base and Headquarters
  5. 3.5 Global Healthcare Apps for Patients Company Product Type and Application
  6. 3.6 Global Healthcare Apps for Patients Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Healthcare Apps for Patients Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Healthcare Apps for Patients Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Healthcare Apps for Patients Market by Type
  1. 4.1 Healthcare Apps for Patients Type Introduction
  2. 4.1.1 iOS
  3. 4.1.2 Android
  4. 4.2 Global Healthcare Apps for Patients Sales Value by Type
  5. 4.2.1 Global Healthcare Apps for Patients Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Healthcare Apps for Patients Sales Value by Type (2021-2032)
  7. 4.2.3 Global Healthcare Apps for Patients Sales Value Share by Type (2021-2032)
5 Healthcare Apps for Patients Market by Application
  1. 5.1 Healthcare Apps for Patients Application Introduction
  2. 5.1.1 Patients
  3. 5.1.2 Relatives of Patient
  4. 5.2 Global Healthcare Apps for Patients Sales Value by Application
  5. 5.2.1 Global Healthcare Apps for Patients Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Healthcare Apps for Patients Sales Value by Application (2021-2032)
  7. 5.2.3 Global Healthcare Apps for Patients Sales Value Share by Application (2021-2032)
6 Healthcare Apps for Patients Regional Value Analysis
  1. 6.1 Global Healthcare Apps for Patients Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Healthcare Apps for Patients Sales Value by Region (2021-2032)
  3. 6.2.1 Global Healthcare Apps for Patients Sales Value by Region: 2021-2026
  4. 6.2.2 Global Healthcare Apps for Patients Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Healthcare Apps for Patients Sales Value (2021-2032)
  7. 6.3.2 North America Healthcare Apps for Patients Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Healthcare Apps for Patients Sales Value (2021-2032)
  10. 6.4.2 Europe Healthcare Apps for Patients Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Healthcare Apps for Patients Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Healthcare Apps for Patients Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Healthcare Apps for Patients Sales Value (2021-2032)
  16. 6.6.2 South America Healthcare Apps for Patients Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Healthcare Apps for Patients Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Healthcare Apps for Patients Sales Value Share by Country, 2025 VS 2032
7 Healthcare Apps for Patients Country-level Value Analysis
  1. 7.1 Global Healthcare Apps for Patients Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Healthcare Apps for Patients Sales Value by Country (2021-2032)
  3. 7.2.1 Global Healthcare Apps for Patients Sales Value by Country (2021-2026)
  4. 7.2.2 Global Healthcare Apps for Patients Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Healthcare Apps for Patients Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Healthcare Apps for Patients Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Healthcare Apps for Patients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medisafe
  2. 8.1.1 Medisafe Company Information
  3. 8.1.2 Medisafe Business Overview
  4. 8.1.3 Medisafe Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medisafe Healthcare Apps for Patients Product Portfolio
  6. 8.1.5 Medisafe Recent Developments
  7. 8.2 Medical ID
  8. 8.2.1 Medical ID Company Information
  9. 8.2.2 Medical ID Business Overview
  10. 8.2.3 Medical ID Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medical ID Healthcare Apps for Patients Product Portfolio
  12. 8.2.5 Medical ID Recent Developments
  13. 8.3 Dminder
  14. 8.3.1 Dminder Company Information
  15. 8.3.2 Dminder Business Overview
  16. 8.3.3 Dminder Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dminder Healthcare Apps for Patients Product Portfolio
  18. 8.3.5 Dminder Recent Developments
  19. 8.4 MyFitnessPal
  20. 8.4.1 MyFitnessPal Company Information
  21. 8.4.2 MyFitnessPal Business Overview
  22. 8.4.3 MyFitnessPal Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MyFitnessPal Healthcare Apps for Patients Product Portfolio
  24. 8.4.5 MyFitnessPal Recent Developments
  25. 8.5 Diabetes:M
  26. 8.5.1 Diabetes:M Company Information
  27. 8.5.2 Diabetes:M Business Overview
  28. 8.5.3 Diabetes:M Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Diabetes:M Healthcare Apps for Patients Product Portfolio
  30. 8.5.5 Diabetes:M Recent Developments
  31. 8.6 Heal
  32. 8.6.1 Heal Company Information
  33. 8.6.2 Heal Business Overview
  34. 8.6.3 Heal Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Heal Healthcare Apps for Patients Product Portfolio
  36. 8.6.5 Heal Recent Developments
  37. 8.7 Eyecare Live
  38. 8.7.1 Eyecare Live Company Information
  39. 8.7.2 Eyecare Live Business Overview
  40. 8.7.3 Eyecare Live Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eyecare Live Healthcare Apps for Patients Product Portfolio
  42. 8.7.5 Eyecare Live Recent Developments
  43. 8.8 AliveCor
  44. 8.8.1 AliveCor Company Information
  45. 8.8.2 AliveCor Business Overview
  46. 8.8.3 AliveCor Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AliveCor Healthcare Apps for Patients Product Portfolio
  48. 8.8.5 AliveCor Recent Developments
  49. 8.9 mySymptoms
  50. 8.9.1 mySymptoms Company Information
  51. 8.9.2 mySymptoms Business Overview
  52. 8.9.3 mySymptoms Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  53. 8.9.4 mySymptoms Healthcare Apps for Patients Product Portfolio
  54. 8.9.5 mySymptoms Recent Developments
  55. 8.10 Teladoc
  56. 8.10.1 Teladoc Company Information
  57. 8.10.2 Teladoc Business Overview
  58. 8.10.3 Teladoc Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Teladoc Healthcare Apps for Patients Product Portfolio
  60. 8.10.5 Teladoc Recent Developments
  61. 8.11 Epocrates
  62. 8.11.1 Epocrates Company Information
  63. 8.11.2 Epocrates Business Overview
  64. 8.11.3 Epocrates Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Epocrates Healthcare Apps for Patients Product Portfolio
  66. 8.11.5 Epocrates Recent Developments
  67. 8.12 Eyecarelive
  68. 8.12.1 Eyecarelive Company Information
  69. 8.12.2 Eyecarelive Business Overview
  70. 8.12.3 Eyecarelive Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Eyecarelive Healthcare Apps for Patients Product Portfolio
  72. 8.12.5 Eyecarelive Recent Developments
  73. 8.13 MyChart
  74. 8.13.1 MyChart Company Information
  75. 8.13.2 MyChart Business Overview
  76. 8.13.3 MyChart Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MyChart Healthcare Apps for Patients Product Portfolio
  78. 8.13.5 MyChart Recent Developments
  79. 8.14 Doximity
  80. 8.14.1 Doximity Company Information
  81. 8.14.2 Doximity Business Overview
  82. 8.14.3 Doximity Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Doximity Healthcare Apps for Patients Product Portfolio
  84. 8.14.5 Doximity Recent Developments
  85. 8.15 Amwell
  86. 8.15.1 Amwell Company Information
  87. 8.15.2 Amwell Business Overview
  88. 8.15.3 Amwell Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Amwell Healthcare Apps for Patients Product Portfolio
  90. 8.15.5 Amwell Recent Developments
  91. 8.16 UpToDate
  92. 8.16.1 UpToDate Company Information
  93. 8.16.2 UpToDate Business Overview
  94. 8.16.3 UpToDate Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
  95. 8.16.4 UpToDate Healthcare Apps for Patients Product Portfolio
  96. 8.16.5 UpToDate Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst